Seres Therapeutics, Inc.

NASDAQ:MCRB

Biotechnology

Healthcare
$5.28 +1.70%

+$0.11 today

Market cap
$51.13M
Beta
0.11
P/E (TTM)
-1.3
EPS (TTM)
-$4.89
52W Low $5.31High $29.98

Volume 0.04M

Average 0.06M

MCRB Total Current Liabilities

All obligations due within one year.

Seres Therapeutics, Inc.NASDAQ: MCRB

Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total current liabilities falls 38.2% from a year ago

Total current liabilities stood at $19.34M at the end of Q1 FY2026, down 38.2% from a year earlier and up 0.1% from the prior quarter. Over 3 fiscal years it compounded at -39.1% a year.

Context

  • Total current liabilities amounted to 16.4% of total assets at the end of Q1 FY2026, down 2.6 pp from a year earlier.
  • Total current liabilities increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total current liabilities keeps falling in the next quarterly balance sheet after a -38.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$19.34M+0.1% QoQ
Last fiscal yearDec 2025
$19.32M-53.1% YoY
Year agoMar 2025
$31.32M-38.2% since
Total Current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-38.2%——
1 year-53.1%——
3-year CAGR-39.1%——
5-year CAGR——
10-year CAGR——

Total Current Liabilities history

USD · from the balance sheet

Latest · FY2025
19.32M USD
Year-over-year change
-53.1%
4-year CAGR
-30.4%

Total Current Liabilities vs competitors

How MCRB compares with its peers on the latest reported figures

  • MCRB's Mar 2026 total current liabilities of $19.34M is the 3rd highest of the 9 companies compared; the peer median is $7.7M.
  • Its year-over-year change of -38.2% is the 5th highest of 9, against a peer median of -33.5%.
  • Total current liabilities amounts to 16.4% of total assets for MCRB, versus a peer median of 18.6%.
MCRB Competitors Peer median
Total Current Liabilities for MCRB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
INOInovio Pharmaceuticals, Inc.Mar 2026$37.92M +38.8%-23.3%76.2%
ABOSAcumen Pharmaceuticals, Inc.Mar 2026$29.23M +51.3%+56.6%21.9%
MCRBSeres Therapeutics, Inc.Mar 2026$19.34M -38.2%-39.1%16.4%
SEERSeer, Inc.Mar 2026$10.24M -22.4%+7.6%3.8%
IRDOpus Genetics, Inc.Mar 2026$9.34M -61.5%+41.4%14.0%
HURATuHURA Biosciences, Inc.Mar 2026$6.07M +26.9%+27.3%20.4%
CGTXCognition Therapeutics, Inc.Mar 2026$6.05M -44.7%+21.3%16.7%
SPROSpero Therapeutics, Inc.Mar 2026$5.49M -81.2%-25.7%9.3%
ACTUActuate Therapeutics IncMar 2026$4.72M -48.4%+9.5%53.0%
Peer median (excluding MCRB) $7.7M-33.5%+15.4%18.6%

Competitors are the stored peer set for MCRB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents180M163.03M127.97M30.79M45.77M
Short-term Investments110.7M18.31M000
Net Receivables0004.75M360K
Inventory0029.65M00
Other Current Assets013.42M17.8M3.13M3.25M
Total Current Assets303.63M194.76M175.41M38.67M49.38M
Property, Plant & Equipment (Net)36.15M133.97M108.03M92.44M80.12M
Goodwill00000
Intangible Assets00000
Long-term Investments495K9.59M9.59M8.67M8.67M
Tax Assets00000
Other Non-current Assets14.59M10.47M65.57M31K31K
Total Non-current Assets51.23M154.02M183.19M101.14M88.82M
Total Assets354.86M348.78M358.6M139.81M138.19M
Account Payables13.74M17.44M3.64M4.08M1.68M
Short-term Debt0456K0010.39M
Tax Payables00000
Deferred Revenue16.82M4.26M7.73M00
Other Current Liabilities21.1M34.77M59.19M17.75M4.57M
Total Current Liabilities82.26M85.6M98.66M41.22M19.32M
Long-term Debt24.64M50.59M101.54M00
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)87M92.43M95.36M00
Other Non-current Liabilities11.5M1.44M16.24M1.84M2.08M
Total Non-current Liabilities141.09M252.41M304.8M84.8M74.65M
Total Liabilities223.35M338M403.46M126.03M93.98M
Common Stock92K125K135K173K10K
Retained Earnings(614.35M)(864.51M)(978.24M)(978.1M)(972.4M)
Accumulated OCI(60K)(12K)000
Other Stockholders Equity00000
Minority Interest00000
Total Equity131.51M10.78M(44.86M)13.78M44.22M
Total Debt49.21M162.59M198.78M91.64M82.97M
Net Debt(130.79M)(440K)70.82M60.85M37.2M

Seres Therapeutics, Inc.

NASDAQ:MCRB

Intrinsic Alpha fair value

Locked

Current Price

$5.28

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.